PDL-1 Expression and Survival in Metastatic Non-small Cell Lung Cancer Patients Who Received Chemotherapy as First-Line Treatment

OBJECTIVE: To show the effect of programmed cell death protein-1 ligand level survival times in patients with metastatic non-small cell lung cancer receiving chemotherapy, to determine the relationship between programmed cell death protein-1 ligand level, neutrophil-to-lymphocyte ratio, and platelet...

Descripción completa

Detalles Bibliográficos
Autores principales: Gürsoy, Pınar, Çakar, Burcu, Günenç, Damla, Nart, Deniz, Çinkooğlu, Akın, Katgı, Nuran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Thoracic Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450090/
https://www.ncbi.nlm.nih.gov/pubmed/35110200
http://dx.doi.org/10.5152/TurkThoracJ.2022.21151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450090/
https://www.ncbi.nlm.nih.gov/pubmed/35110200
http://dx.doi.org/10.5152/TurkThoracJ.2022.21151

Ejemplares similares